UTP25 and Alzheimer disease: The most significant differences in expression between WT and AD groups appeared on day 10, when 13 out of 14 AMPs, including AttA, AttB, AttC, AttD, CecA1, CecA2, CecB, CecC, DptA, DptB, Drs, Def, Dro, and Mtk, showed a remarkable decline in the AD group, with log2 fold changes of -1.816, -1.182, -2.011, -4.250, -2.065, -1.455, -2.735, -1.813, -3.011, -2.184, -3.525, -2.173, and -1.975, respectively (Figure 2B).